Tyrosine kinase inhibitors (TKIs) are a class of drugs that block the action of enzymes called tyrosine kinases. These enzymes are responsible for the activation of many proteins by signal transduction cascades, which can contribute to the growth and spread of cancer cells. By inhibiting these enzymes, TKIs can help to stop or slow the progression of cancer.
